In a groundbreaking endeavor poised to revolutionize the fight against drug-resistant bacteria, researchers from Stanford University and McMaster University have harnessed the power of artificial intelligence (AI) to design a new generation of AI-engineered antibiotics. Employing cutting-edge AI algorithms, the team has developed a pioneering platform, dubbed SyntheMol, to tackle the pressing global health threat
